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Abstract– Calcium is the primary signalling component of excitation-contraction coupling, the process
linking electrical excitability of cardiac muscle cells to coordinated contraction of the heart. Understanding
Ca2+ handling processes at the cellular level and the role of intercellular communication in the emergence
of multicellular synchronization are key aspects in the study of arrhythmias. To probe these mechanisms,
we have simulated cellular interactions on large scale arrays that mimic cardiac tissue, and where individ-
ual cells are represented by a mathematical model of intracellular Ca2+ dynamics. Theoretical predictions
successfully reproduced experimental findings and provide novel insights on the action of two pharmaco-
logical agents (ionomycin and verapamil) that modulate Ca2+ signalling pathways via distinct mechanisms.
Computational results have demonstrated how transitions between local synchronisation events and large
scale wave formation are affected by these agents. Entrainment phenomena are shown to be linked to both
intracellular Ca2+ and coupling-specific dynamics in a synergistic manner. The intrinsic variability of the
cellular matrix is also shown to affect emergent patterns of rhythmicity, providing insights into the origins
of arrhythmogenic Ca2+ perturbations in cardiac tissue in situ.
Keywords– Membrane potential, Intra cellular oscillator, Coupling, Synchronisation, Complex dynami-
cal system, Emergence.
INTRODUCTION
Our present understanding of cardiovascular function, in terms of biological activity at the cellular
and tissue level reflects, to a large extent, the simplicity with which we extrapolate information
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obtained from (reductionist) experimental approaches into multiple complex processes.4, 9 Our
perspective on cell signalling, for instance, is supported by a reasonably detailed view of multi-
level processing pathways, signal integrators and biological oscillators, but our understanding of
how these are integrated to coordinate synchronised biological responses in situ remains to be fully
defined.4, 14, 15, 28, 40 As a consequence, there is a clear need to develop new approaches that link
investigations of the organisation and coordination of cardiovascular cell and tissue function to the
underlying interrelationships between molecules and cellular signalling pathways.6, 15–17
In the myocardium, the electrical activity largely depends on the coordination of excitatory
stimuli as they propagate through the tissue. At the cellular level, excitation-contraction coupling
(ECC) – the process linking electrical excitability to physical contraction – involves the opening
of surface-membrane Na+ channels (depolarisation) which triggers potential-dependent influx of
calcium ions (Ca2+ ) through L-type Ca2+ channels (also known as voltage-operated Ca2+ chan-
nels, VOCCs) and the subsequent Ca2+ -induced Ca2+ release (CICR) via ryanodine receptors
(RyR).1 The ensuing rise in intracellular Ca2+ drives actin-myosin cross-bridge formation and
thus myocardial contraction. However, the synchronised contraction of the entire myocardium is
dependent on the functional coupling of cardiac myocytes into a well-organised syncytium which
can appropriately respond to neurohumoral inputs (e.g. increased adrenergic drive during exercise
or periods of stress).38 Normal heart function is therefore critically dependent on the complex
regulation and encoding of intracellular Ca2+ signals that are synchronised across large regions of
the myocardium via mechanical and electrical coupling between cells.5, 7, 16
Accordingly, defects in cellular Ca2+ handling associated with arrhythmogenesis are also sub-
ject to dynamical interactions that depend on the state of neighbouring cells,33, 37 i.e. intercellular
communication and, to an extent which remains to be quantified, on differences between cells of
the same tissue. Biological variability, sometimes perceived as a lack of predictability, can be an
important driving mechanism behind pattern formation in self-organising systems. Cell-to-cell dif-
ferences may determine patterns on larger scales, arising from a breaking of spatial symmetry, and
which may be related to local synchronisation.20, 26 When a source of ‘randomness’ is introduced
in the system, such phenomena have been shown to arise in model populations.13, 18 However, in
cardiac as well as in other vascular tissue, dissociating the role of intercellular communication from
that of the intracellular generative components remains elusive. A combined approach employing
mathematical representation of a broad range of experimental observations is therefore required to
gain new insights into the phenomena of cardiac tissue synchronisation and the onset of arrhyth-
mogenesis that results from desynchronisation within single cells and across cell populations.
At the sub-cellular and cellular level, theoretical modelling has been useful to describe dynam-
ical features associated with a cell’s oscillatory behaviour,27 but the structure of such systems is
inherently different from that of a population of cells. At a spatial scale larger than the individual
myocyte, intercellular connections must be considered to understand how the interactions between
cellular CICR and cell-to-cell communication manifest themselves at the tissue level.22 Our results
show that different patterns of wave formation may arise from the reciprocal influence of individ-
ual elements, when they are subject to a certain degree of variability. Using a model of coupled
oscillator-based synchronization of Ca2+ oscillations, we investigate how cell variability affects
Ca2+ handling, when cells are subject to the action of Ca2+ -perturbing pharmacological agents.
We use the Ca2+ ionophore ionomycin and verapamil, a drug commonly used for the treatment of
arrhythmias. In the present study, we propose a multicellular framework, able to interpret findings
from experimental observations at the cellular level, and extrapolate these to the global activity of
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a model layer of cells through complex non linear interactions, electrical connectivity and modes
of intercellular synchronization. We first present a comparative analysis, where population results
are contrasted with individual cells’ behaviour, revealing the variability in the dataset. We then use
this concept of variability to justify how intercellular Ca2+ handling and cell-to-cell coupling may
be expected to affect the Ca2+ -dependent processes underlying the arrhythmogenic substrate.
MATERIALS AND METHODS
Experimental Methods
HL-1 cells are immortalized atrial-derived cells that maintain cardiac cell phenotype (including
physical contraction, electrical connectivity and Ca2+ coupling) through serial passage.3 HL-1
cells were cultured on gelatin-fibronectin matrices on glass-bottomed coverslips (14mm diameter)
in a humidified, 5% CO2 environment at 37°C as described in George et al.8 Cells were seeded to
achieve an initial density of 30-50% confluency (700-1000 cells mm−2 – a density at which they are
non-contractile and do not exhibit well-organised large-amplitude calcium oscillations) and then
subsequently grown to higher densities until they formed spontaneously-contractile monolayers
(typically > 2000 cells mm−2) normally day 2-3 days post-seeding. Prior to Ca2+ imaging HL-
1 cell monolayers, selected on the basis of a defined rate of physical contraction between 0.6
and 2Hz, were maintained in supplemented Claycomb medium containing ionomycin (0.1-100nM,
from a 1mM stock in dimethyl sulfoxide (DMSO)) or verapamil (100nM-1µM, from a 10mM stock
in H2O) for 3h. HL-1 monolayers which had not been exposed to either drug were used as controls.
Fluorescence Measurements
Fluo4 is a fluorine-substituted analogue of the widely used fluo3 Ca2+ indicator which has favou-
rable signal intensity and Ca2+ -binding kinetic properties. To load HL-1 cells with fluo4 (Life
Technologies), control HL-1 monolayers or those that had been incubated with ionomycin or vera-
pamil for 3h were switched into supplemented Claycomb media (with or without drug as appropri-
ate) containing 5µM fluo-4-acetoxymethyl ester (AM) (from a 1mM stock in DMSO) for a further
1h at 37°C. Following this period, coverslips were flooded with 1ml unsupplemented Claycomb
(to avoid fluorescent artefact arising from fetal bovine serum) and left for a further 15min to enable
de-esterificiation of fluo-4-AM and the liberation of fluorescent ‘free’ fluo-4 in the cytoplasm of the
cells. This protocol exposed the cells to the required concentration of Ca2+-perturbant (ionomycin
or verapamil) for a total of 4h. Coverslips were transferred to the stage of a confocal laser scanning
microscope (CLSM) (SP5, Leica Microsystems) fitted with a 63X oil-immersion objective (numer-
ical aperture (NA) of 1.4) maintained at 37°C in an environmental chamber. Following stabilization
(2-3min) and in order to visualise Ca2+ -dependent fluo-4 signals (excitation maximum at 494nm,
emission maximum 516nm) cells were illuminated using a 488nm Argon laser at 30% maximum
power and fluorescent outputs (494-550nm) were captured using a photomultiplier tube (PMT).
Images were acquired every 36ms in a rectangular field of view (FOV) comprising 512x256 pixels
(approximately 0.011mm2, typically 30 cells per FOV). For each coverslip, data corresponding to
Ca2+ -dependent fluo-4 signal fluctuations with time were subsequently extracted from 50x50µm
regions of interest (ROI) using Leica LAS-AF software and transposed into csv files. Each ROI
corresponded to a single cell within the FOV.
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Mathematical Formulation
At the ultra-structural level, coupling via CICR between the sarcoplasmic reticulum (SR), intra-
cellular Ca2+ transients and sarcolemmal fluxes constitute one of the fundamental component that
underlies ECC. Calcium entering the cell via VOCCs binds to the ryanodine-sensitive SR-Ca2+ re-
lease channel, allowing rapid Ca2+ efflux from the SR.38 Once released into the cytosol, Ca2+ is
either pumped out of the cell, or resequestered by the stores, generating requirements for influx of
extracellular Ca2+ across the sarcolemma to sustain the oscillatory activity. In the present formu-
lation, each cell is modelled as a Ca2+ oscillator that generates oscillations via CICR. The extra-
cellular influx is provided via Ca2+ -permeable non-selective cation channels (NSCCs), VOCCs
and reverse mode Na+ -Ca2+exchange (NCX). Membrane potential is mainly influenced by the
balance between K+ and Cl− gradients, and by the NCX, depending on whether the exchanger
operates in forward or reverse mode.29, 30
The oscillator is represented by a third-order system of coupled non linear differential equa-
tions, as described by Eqs. (A-1). Simulations are produced by numerical integration of this system
on a rectangular domain, representing a monolayer of approximately 6000 cells. We use a Runge-
Kutta-Merson algorithm with adaptive time stepping and error control. Unless otherwise sated, all
the values of the fixed coefficients employed in the simulations are taken from Parthimos et al.29, 30
and given in Table 1.
Coupling Electrical and chemical transmission across cells occurs through aggregates of inter-
cellular channels called gap junctions that connect the cytoplasm of adjacent cells in a multicellular
population. Ca2+ coupling may effectively arise via intracellular Ca2+ waves or local increases
in concentration, or via triggered release by more rapidly diffusing signalling effectors, such as
InsP3.24, 38 Alteration of gap junction organisation, discontinuities of myocardial architecture, in-
homogeneities and/or structural heterogeneity arising from multiple factors may modulate action-
potential conduction (see Rudy32 and references therein), and are a consistent feature of heart
disease.34 In scenarios where the intracellular Ca2+ buffering power is reduced (e.g. arrhythmo-
genic diseases such as CPVT2) it is plausible that intercellular Ca2+ diffusion may also play a
greater role.31 The prescribed coupling conditions, as described below, reflect these scenarios to
various degrees.
In the model, interactions between cells are determined by the network topology, and a cell-
specific parameter that allows each cell to couple to its nearest neighbours via Ca2+ permeabil-
ity (gCa) and electrical conductance (gz). Distinct values of gCa and gz are assigned to each
cell,2, 23, 25, 29 and incorporated in Eqs. (A-1), as described by Eqs. (A-2). We use a Box-Muller
transform to generate a pseudo-random Gaussian distribution of each parameter, with a given mean
and coefficient of variation, to allow a control over the variability in the conductance states and gap-
junctional permeabilities. Mean values of gCa, gz and associated coefficient of variations are given
in the text.
RESULTS
Computational results generated for the entire domain are compared with experimental observa-
tions. To validate theoretical predictions in terms of Ca2+ dynamics, information from clusters
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of cells and single cells from 6 different numerical FOV are arbitrarily selected within the com-
putational domain, each containing between 20 and 30 cells, in order to best correspond to the
experimental FOV. For most simulations, mean values of the Ca2+ coupling coefficient were in
the range 0s−1< gCa <1s−1, although results were obtained for values of up to gCa=5s−1. Elec-
trical coupling is mostly maintained at mean values of either gz=500s−1 or gz=1000s−1, and all
distributions have a coefficient of variation of 0.2, unless otherwise stated. The effects of varying
Ca2+ influx via NSCCs, represented by parameter A in Eq. (A-1a), and via VOCCs, represented
by parameter ECa in both Eqs. (A-1a) and (A-1c), were investigated.
Effects of Ionomycin and Ca2+ Entry via NSSCs
The Ca2+ ionophore ionomycin was employed to raise the intracellular level of Ca2+, primar-
ily via direct Ca2+ influx across the membrane (down its concentration gradient, as extracellular
Ca2+ is approximately 1.3mM). Numerically, the action of ionomycin is reproduced by increas-
ing parameter A and thus the Ca2+ influx in the cytosol via NSCCs. As previously described, the
value of A was distributed across the matrix, with three mean values of A=2.3µM s−1, A=2.8µM s−1
and A=3.3µM s−1. These values extend through the physiological parametric range associated with
Ca2+ oscillations.29, 30
Time series of intracellular Ca2+ concentrations obtained with the mathematical model are
extracted for each numerical FOV, as explained above, and selected ROI (each ROI representing
an individual cell within a multicellular population) are compared with time series of Ca2+ fluo-
rescence obtained experimentally for increasing concentrations of ionomycin (Fig. 1). Increasing
parameter A results in an average increase in cytosolic Ca2+ concentration, but a decrease in the
oscillatory amplitude, with increasing variations in frequency (Fig. 2a). It can be observed that the
chosen parametric range (numerical simulations) gives rise to a division in the data, where control
is in effect contrasted with all other results for increasing concentrations of ionomycin. Results for
the complete dataset shown in Fig. 2a also reveal an increase in variability in the experimental am-
plitudes. Nullcline analysis for single cell dynamics confirmed the large variations in amplitude,
but not the changes in oscillatory frequency observed. Indeed, two dimensional phase diagrams
depicted in Fig. 3 reveal how an increase in A is associated with a decrease in the size of the limit
cycle and an upward translation in the range of working membrane potentials. This discrepancy
is an important point of emergent cluster dynamics that is considered further in the Discussion.
Variations in A do not influence directly the position of the y-nullcline, but equilibria are translated
downwards, with a marked contraction of the Ca2+ release phase of the oscillatory mechanism.
Effects of Verapamil and Interaction Between NSSCs and VOCCs
To understand how cells synchronise their activity, and under which ‘conditions of coupling’ a
global entrainment occurs, we study the interdependence of intracellular Ca2+ and membrane
potential, with respect to both NSSCs and VOCCs. Interaction mechanisms between influx via
NSSCs and via VOCCs were briefly investigated in Parthimos et al.,30 where the action of the
PLC inhibitor U73122 was modelled as a reduction in coefficient A (Ca2+ influx via NSSCs), and
the action of the VOCC blocker nifedipine was simulated by a reduction in the coefficient ECa
(Ca2+ entry via VOCCs). Results demonstrated the crucial role of Ca2+ influx in maintaining
oscillatory activity. In this study, we use verapamil, a Ca2+ channel antagonist, that has distinct
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effects on cardiac electrophysiology and is used clinically as an antiarrhythmic.19 In the mathemat-
ical formulation, increasing concentrations of verapamil are modelled as a reduction in Ca2+ entry
through VOCCs by decreasing the value of the parameter ECa in Eqs. (A-1a)-(A-1c). Variations are
governed by a single parameter value, identical for each cell, and reducing this parameter is con-
sequently done uniformly (no distribution). As for previous simulations, control cases are defined
by a reference value.29, 30
Time series of intracellular Ca2+ obtained with the mathematical model are compared with
experimental results for increasing concentrations of verapamil in Fig. 4. Results are extracted for
each numerical FOV, as previously described, and selected ROI are compared with time amplitude
series of Ca2+ fluorescence. The ability of verapamil to both enhance or suppress oscillations, seen
in experimental observations, is reproduced by the numerical results (e.g. differential response of
top and bottom traces in Fig. 4 panels (a) and (b), both theoretically and experimentally, after
the administration of verapamil). This bi-stable behaviour reveals a close relationship between
the two Ca2+ uptake mechanisms investigated here. If Ca2+ uptake via NSCCs is high, reduc-
tions in ECa can induce a transition from a small amplitude to a large amplitude limit cycle (light
green to yellow in Fig. 5). By contrast, under low NSCC Ca2+ uptake conditions, verapamil can
suppress oscillatory activity by shifting the limit cycle onto a stable/non-oscillatory node at high
[Ca2+]SRvalues. Results for the complete dataset represented in Fig. 2b show that this behaviour
is invariably associated with a reduction in frequency; but depending on the distribution of A, am-
plitude responses to ECa may be different than the one shown in Fig. 2b (left). These scenarios are
investigated further as manifestations of emergent synchronization/desynchronization events in the
following section.
Dynamics of Large Scale Wave Formation
The role of pharmacological agents, such as ionomycin, in the emergence of global and local wave
patterns has been investigated in an extended array of coupled cells (Fig. 6). Under higher val-
ues of A, representing increased concentrations of ionomycin (Fig. 6; top to bottom), well defined
wave fronts (A=1.3µM s−1) are converted into localised low amplitude fluctuations (A=3.3µM s−1)
resembling cardiac fibrillation patterns. This transition is partly due to the fact that high intracellu-
lar concentration of Ca2+ will suppress oscillatory activity in segments of the cellular population,
and thus introduce a degree of uncoupling within the cellular matrix. The onset of this marked
transition from global to local wave activity is dependent on the operating point within the para-
metric space. Indeed, a different value of ECa shifts the point of transition into fibrillation patterns
(Fig. 6), thus illustrating the underlying synergy between the two Ca2+ uptake mechanisms. More
specifically, the action of verapamil (reduction of ECa) can induce both the emergence (lower pan-
els in Fig. 6 from left to right) or the suppression (middle/upper panels in Fig. 6 from left to right)
of oscillatory activity, in agreement with experimental observations. The key to this bi-stable re-
sponse is the underlying availability of Ca2+ (simulated here as different Ca2+ uptake rates on
the cellular level, from A=1.3µM s−1 to A=3.3µM s−1). This overview explains the undesirable
contractile side-effect of verapamil as a consequence of reduced Ca2+ influx, and thus impaired
CICR.
In order to investigate the role of variability in coupling strength against the variability of indi-
vidual cells in terms of Ca2+ sequestration capacity, we dispersed simultaneously the distributions
of parameters A and gCa. At the cellular level, the rate of Ca2+ uptake determines the level of
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Ca2+ sequestration within the stores and, in consequence, the period and amplitude of the primary
CICR oscillator. Coupling a large array of such oscillators via membrane potential or Ca2+ fluxes
can produce population level dynamics that are dependent, not only on the strength of the coupling,
but most importantly on its variability across the array. The emergence of such patterns when the
underlying intracellular (A) and intercellular (gCa) distributions become more pronounced is sum-
marised in Fig. 7. An increase in the coefficient of variation of A (from CVA=0.01 to CVA=0.2)
convert persistent plane waves of Ca2+ into irregular oscillatory activity, concentrated around a
number of ‘pacemaking’ clusters. When the coefficient of variation of gCa is simultaneously in-
creased (CVgCa=0.1, 0.15 and 0.3) the wave patterns are further destabilised, highlighting a synergy
between intracellular and intercellular Ca2+ handling (Fig. 7). Interestingly, the regularity of the
waveforms is least affected for CVA=0.01, even for higher values of CVgCa , suggesting that the
system is more robust when the cellular array is in a more uniform state. For a given dispersion
of A, however, the influence of these ‘pacemaking’ clusters gradually disappear when its value is
increased, showing how a persistent increase in intracellular concentration of Ca2+ may have an
effect analogous to cellular uncoupling, as previously mentioned. This can be seen in the transition
from top to bottom in Fig. 6, and despite the fact the coupling conditions are identical.
DISCUSSION
The role of Ca2+ availability and intra- and/or intercellular handling in the onset of coherent os-
cillatory activity has been studied through mathematical modelling of cellular dynamics across
extended arrays of interconnected cells. Theoretical findings were compared to experimental
evidence under specific pharmacological interventions. We have employed two pharmacologi-
cal agents that have established mechanisms of action in modulating main cellular Ca2+ cycling.
First, the Ca2+ ionophore ionomycin, that leads to rises in intracellular Ca2+ levels by allowing
direct Ca2+ influx across the surface membrane and, to a lesser extent, by activating endogenous
Ca2+ entry pathways. Second, verapamil, a L-type voltage-operated channel antagonist that atten-
uates the Ca2+ influx driven by surface membrane depolarisation, and thus modulates homeostatic
Ca2+ influx-efflux balance in spontaneously oscillatory cardiac cells. It is important to note that
exposure of cells to these pharmacological agents that perturb intracellular Ca2+ handling via dif-
ferent pathways would be expected to manifest as altered intercellular Ca2+ dynamics. Moreover,
due to the interlinked nature of cellular Ca2+ signalling pathways, both ionomycin and verapamil
would be expected to evoke compensatory adaptations in Ca2+ cycling.
Experimental and theoretical results on the action of ionomycin have demonstrated a tendency
to reduce oscillatory frequency of a nearly harmonic signal and unmask complex dynamical fea-
tures such as period doubling and mixed mode oscillations. Such findings conform with long
existing theories that arrhythmogenesis can be regarded as a dynamical process.10, 12 The most
important feature of the action of ionomycin is the reduction of oscillatory frequency observed
experimentally (Fig. 1 and Fig. 2). This is contrary to theoretical results for single cell dynamics,
illustrated by the nullcline and limit cycle analysis in Fig. 3, and highlights the point that Ca2+ han-
dling in an extended array of interconnected cells can introduce coupling-specific dynamics. The
evolution of oscillatory activity presented in Fig. 1 is due to the transition of individual cellular dy-
namics from a non-oscillatory node to slow/large amplitude to fast/low amplitude oscillations that
are eventually suppressed (see limit cycle transition in Fig. 3). Increased intracellular Ca2+ con-
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centrations across the array will, therefore, suppress the faster cells while simultaneously initiate
slow/large amplitude oscillations in previously quiescent cells that subsequently dominate the os-
cillatory profile of the extended matrix. This effective spatial heterogeneity may lead to variability
in signals (both within and between cells) and thus predispose to intercellular desynchronization.
Indeed simulations demonstrate that different groups of oscillators dissociate into coherent and
incoherent regions, resulting in desynchronisation of the entire population.
Although similar in nature, the effect of verapamil on reducing cellular Ca2+ uptake has been
long associated with a bi-stable response, due to its ability to selectively enhance or suppress os-
cillatory activity. This effect is indeed illustrated in Fig. 4, where two apparently similar control
signals (first and third row) are differentially enhanced or suppressed. This result, matched by the
numerical simulations, has been previously attributed to the available Ca2+ levels within individual
cells, thus providing a direct link between NSCC and VOCC influx.29, 30 A further hypothesis on
the impact of verapamil on this scheme is based on its potency as a hERG-K+ channel blocker.43
Such an effect will lead to cellular depolarisation, which in turn activates VOCCs influx, thus
negating part of the action of verapamil. Although this further assumption is not necessary for pro-
ducing the bi-stable response associated with VOCC blockage, the effect on membrane potential
remains central as illustrated in Fig. 5. Although not shown, effects of varying the gz distribution
are less important. They reflect on the oscillatory patterns, and can be attributed mainly to the
role of VOCCs, as Ca2+ influx through NSCCs is not directly associated with membrane potential
changes (see nullcline analysis in Fig. 3).
To elucidate the role of gap junctions in mediating ECC, we have investigated how variability
in the distribution of gCa is affected by the intracellular components of Ca2+ handling, represented
by the distribution of the parameter A (Ca2+ entry via NSCCs). Increase in the coefficient of
variation of parameters A (CVA) and gCa (CVgCa) is physiologically equivalent to ‘thinning’ the
substrate matrix in a manner similar to that resulting from muscle pathology associated with apop-
tosis (heart failure) or muscular trauma (myocardial infarction). Importantly the two coefficients
mimic such effects in dynamically distinct ways. As a consequence, when the range of Ca2+ up-
take by individual cells is extended (increased CVA), a subset of cells will become quiescent due to
low Ca2+ availability, whereas a second subset will reach a non-oscillatory state due to over stim-
ulation by high influx of Ca2+. Individual cells will respond differentially to intracellular feedback
mechanisms. Populations of cells will therefore remain non-responsive to intercellular stimulation,
in effect thinning the cellular array. By comparison, increasing CVgCa can be thought of as provok-
ing regional changes in the quantity and organisation of gap junctions. As seen in Fig. 7, regular
oscillatory activity can be disturbed by increasing either coefficients of variation. Interestingly,
when the cellular matrix is more uniform (CVA=0.01) an increase in CVgCa does not disturb the es-
tablished wave forms. The findings summarised in Fig. 7 suggest a synergy between the A and gCa
distributions, i.e. between the intracellular and intercellular components of Ca2+ handling. Such a
synergy, which has not been fully explored in the present context, may provide subtle insights into
the emergence of arrhythmic states in cardiac tissue.
In summary, we have shown how coupling in an extended array of cells can introduce dynam-
ical interactions that are significantly different than those conjectured by single-cell models. Our
observations support the hypothesis that Ca2+ movements at the sub-cellular and cellular level
may coordinate Ca2+ events at a larger scale to produce global responses. These are dependent on
properties of the cellular matrix, as may be reflected by varying the dispersion of distributions of
the parameters A (Ca2+ entry via non-selective cation channels) and gCa (representing Ca2+ per-
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meability/diffusion under various dysfunctional states). As suggested by previous experimental
evidence, Ca2+ handling and cell-to-cell coupling are closely related, and such variations would
indeed be expected to influence the Ca2+ -dependent processes underlying excitation-contraction
coupling and the arrhythmogenic substrate.21, 35, 36, 39, 41, 42
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(b) verapamil. The relative amplitude describes the fold difference between the peak Ca2+ oscillation
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FIGURE 3. Nullcline analysis of the action of varying Ca2+influx via NSSCs. Phase diagram
for changes in the parameter A, with (a) membrane potential held constant at −30mV, and (b)
[Ca2+]SR held constant at 1µM. Dark green colour is for A=2.3µM s−1, light green colour for
A=2.8µM s−1, and yellow colour for A=3.3µM s−1. x-nullclines ([Ca2+]i ) are coloured according to the
same pattern. Results are presented for an arbitrary cell within the computational domain, and take
into account coupling conditions. Assorted phase plots and equilibria are obtained for different cells,
but all present the same generic characteristics.
FIGURE 4. Comparison of numerical results and experimental traces for increasing concentrations
of verapamil. (a) Control (no drug) and (b) 100nM-1µM. For each figure, the left panel corresponds to
the time amplitude series of Ca2+ fluorescence, obtained from the experiments. The right panel (grey
lines) represent the time amplitude series of Ca2+ oscillations obtained with the mathematical model.
The mean [Ca2+]i value (in µM) in each scenario is given on the right hand side of each trace.
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FIGURE 5. Nullcline analysis of the action of Ca2+ influx via VOCCs. Phase diagram for changes in
the parameter ECa with (a) membrane potential held constant at −30mV, and (b) [Ca2+]SR held con-
stant at 1µM. From dark green to yellow ECa=18µM V−1 s−1, ECa=12µM V−1 s−1, and ECa=2µM V−1 s−1.
x-nullclines ([Ca2+]i ) are coloured according to the same pattern. Arrow shows the transition towards
a stable equilibrium as ECa is further reduced. Results are presented for an arbitrary cell within the
computational domain, and take into account coupling conditions. Assorted phase plots and equilibria
are obtained for different cells, but all present the same generic characteristics.
FIGURE 6. Effect of simultaneously varying A (reproducing increasing concentrations of ionomycin)
and ECa (reproducing increasing concentrations of verapamil). Transition starts from a lower value of
A=1.3µM s−1. Coefficient of variations (CVA and CVgCa) and coupling conditions are identical for all
figures. Red colour represent [Ca2+]i, green the stored concentration [Ca2+]SR, and blue the membrane
potential. A purple/magenta colour is seen where red and blue strengths are equal, and therefore
indicative of membrane depolarisation and high Ca2+ influx.
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FIGURE 7. Effect of simultaneously varying the coefficient of variation for the A distribution (CVA)
and for the gCa distribution (CVgCa). The mean value of A is identical for all figures, and coupling is
maintained at the same level. Colour coding as in Fig. 6
19
A APPENDIX
A.1 Mathematical Formulation
For each individual cell, the system is described by three variables: x=[Ca2+]i represent the cytoso-
lic free Ca2+ concentration, y=[Ca2+]SR the Ca2+ concentration in the SR and z the cell membrane
potential.
dx
dt = A
NSCC
influx
− ECa z−zCa11+e−(z−zCa2)/RCa
VOCC influx
+ ENa/Ca xx+xNa/Ca
(
z− zNa/Ca
)
NCX
(A-1a)
− B x
n
xn+xnb
SR uptake
+ Cr x
pr
xpr+xprr
ymr
ymr+ymrr
RyR CICR
− Dxk
(
1+ z−zdRd
)
Ca2+extrusion
+ Ly
SR leak
dy
dt = B
xn
xn+xnb
SR uptake
− Cr x
pr
xpr+x
pr
r
ymr
ymr+ymrr
RyR CICR
(A-1b)
dz
dt =−γ
(
ECl xx+xCl (z− zCl)
Cl−channels
+ 2ECa z−zCa11+e−(z−zCa2)/RCa
VOCC influx
(A-1c)
+ ENa/Ca xx+xNa/Ca
(
z− zNa/Ca
)
NCx
+ EK (z− zK) x
x+βe−(z−zCa3)/RK
K+efflux
)
The electric reversal potentials with respect to Ca2+ and Na+ are determined from the Nernst
equation, see Parthimos et al. for details.29, 30 The different terms and associated fixed parameter
values can be found in Table 1. The subscript r refers to RyR-mediated CICR, as opposed to
InsP3-induced Ca2+ release (not included in the present formulation).
For each SMC i, the set of its nearest neighbours j ∈ Ni consist of at most 6 neighbours,
disposed at the vertices of an hexagon, depending on its position within the domain or at the
boundary. Two terms:
JCa,i = gCa ∑
j∈Ni
(
x j− xi
)
Vm,i = gz ∑
j∈Ni
(
z j− zi
) (A-2)
are added to (A-1a) and (A-1c), respectively, to model Ca2+ and electrical coupling.
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TABLE 1. Terms and coefficients associated with the system of equation
Parameter Description Value
A Ca2+ influx via NSCC variable
L SR leak rate constant 0.025s−1
γ scaling factor (inversely related to cell capacitance) 1VµM−1
VOCC influx
ECa whole cell conductance variable
zCa1 reversal potential 0.12 to 0.135V
zCa2 half point of activation sigmoid −0.024V
RCa max. slope of activation sigmoid 0.0085V
NCX
ENa/Ca whole cell conductance 43.8µM V−1 s−1
zNa/Ca reversal potential −0.03 to −0.045V
xNa/Ca half point of Ca2+activation 0.5µM
SR uptake
B rate constant 400µM s−1
xb half point of ATPase activation sigmoid 4.4µM
n Hill coefficient 2
RyR CICR
Cr rate constant 1250µM s−1
yr half point of Ca2+efflux sigmoid 8.9µM
xr half point of CICR activation sigmoid 0.9µM
mr Hill coefficient 2
pr Hill coefficient 4
Ca2+extrusion by ATPase pump
D rate constant 6.25µM s−1
zd intercept of voltage dependence −0.1V
Rd slope of voltage dependence 0.25V
k exponent for [Ca2+]idependence 2
Cl−channels
ECl whole cell conductance 65µM V−1 s−1
zCl reversal potential −0.025V
xCl Ca2+sensitivity 0µM
k exponent for [Ca2+]idependence 2
K+efflux
EK whole cell conductance 43µM V−1 s−1
zK reversal potential −0.095V
zCa3 half point of KCa channel activation sigmoid −0.027V
RK max. slope of KCa channel activation sigmoid 0.012V
β Ca2+sensitivity of KCa channel activation sigmoid 0µM
22
